###begin article-title 0
Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 114 122 114 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 67 73 <span type="species:ncbi:9606">humans</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
A deficiency in Perk (EIF2AK3) causes multiple neonatal defects in humans known as the Wolcott Rallison syndrome. Perk KO mice exhibit the same array of defects including permanent neonatal diabetes (PND). PND in mice was previously shown by us to be due to a decrease in beta cell proliferation and insulin secretion. The aim of this study was to determine if acute ablation of PERK in the 832/13 beta cells recapitulates these defects and to identify the primary molecular basis for beta cell dysfunction.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insulin </italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA </italic>
###xml 313 321 313 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
The INS1 832/13 transformed rat beta cell line was transduced with a dominant-negative Perk transgene via an adenoviral vector. AdDNPerk-832/13 beta cells exhibited reduced expression of insulin and MafA mRNAs, reduced insulin secretion, and reduced cell proliferation. Although proinsulin content was reduced in AdDNPerk-832/13 beta cells, proinsulin was abnormally retained in the endoplasmic reticulum. A temporal study of the acute ablation of Perk revealed that the earliest defect seen was induced expression of two ER chaperone proteins, GRP78/BiP and ERp72. The oxidized states of ERp72 and ERp57 were also increased suggesting an imbalance in the redox state of the ER.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Acute ablation of Perk in INS 832/13 beta cells exhibited all of the major defects seen in Perk KO mice and revealed abnormal expression and redox state of key ER chaperone proteins. Dysregulation of ER chaperone/folding enzymes ERp72 and GRP78/BiP occurred early after ablation of PERK function suggesting that changes in ER secretory functions may give rise to the other defects including reduced insulin gene expression, secretion, and cell proliferation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 899 900 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1349 1350 1349 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1502 1503 1502 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1504 1506 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1677 1679 1677 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1800 1805 1800 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 1970 1971 1970 1971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 2014 2018 2014 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 2426 2430 2426 2430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 2547 2552 2547 2552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 2709 2713 2709 2713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 814 820 <span type="species:ncbi:9606">humans</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 1562 1568 <span type="species:ncbi:9606">humans</span>
###xml 1573 1577 <span type="species:ncbi:10090">mice</span>
###xml 1815 1819 <span type="species:ncbi:10090">mice</span>
###xml 2441 2445 <span type="species:ncbi:10090">mice</span>
###xml 2724 2728 <span type="species:ncbi:10090">mice</span>
Monogenic forms of permanent neonatal diabetes have revealed key aspects of the development and function of the insulin secreting beta cells [1]. Mutations in Perk (EIF2AK3) underlies the complex genetic disorder of the Wolcott Rallison syndrome, which includes permanent neonatal diabetes (PND), exocrine pancreas deficiency, growth retardation, hepatic dysfunctions, and skeletal dysplasias [2,3]. All of the dysfunctions in WRS are mirrored in mice deficient for PERK [4,5], and detailed genetic studies in mice have shown that the diabetes is caused by the loss of expression of PERK in the insulin secreting beta cells [6], whereas the exocrine pancreas deficiency is caused by the absence of PERK in the pancreatic acinar cells [7]. The initial interpretation of the molecular basis of these dysfunctions in humans and mice was based upon studies performed in vitro with cultured fibroblasts [8]. These studies showed that the catalytic domain of PERK resides in the cytoplasm where it phosphorylates the translation initiation factor eIF2 alpha, which results in either repression of global protein synthesis or activation of translation of specific mRNAs encoding gene regulatory proteins. PERK regulatory domain resides in the lumen of the ER and is controlled by the binding of the ER chaperone proteins, GRP78/BiP and GRP94, and calcium [9]. Disturbances in the ER such as ER stress and accumulation of unfolded proteins, or normal physiological changes in calcium levels can activate PERK [9,10]. Based upon these studies it was proposed that PND in humans and mice deficient in PERK was caused by uncontrolled ER stress and apoptotic cell death of the beta cells [11]. However a recent comprehensive analysis of the islet and beta cell development revealed that the cause of diabetes in Perk deficient mice is due to failure to expand beta cell mass and defects in beta cell development and insulin secretion during the critical fetal and neonatal periods [6]. Thus three distinct defects are seen in Perk-deficient beta cells, which raises questions about the causal connection and progression of beta cell dysfunction. The chronic loss of PERK expression over the four-week period between when defects in beta cell development are first seen during the fetal stage and the onset of overt diabetes three weeks after birth confounds resolving these questions and determining the molecular basis of the defects in Perk-deficient mice. To investigate the acute effects of PERK ablation we have expressed a dominant negative mutation of Perk in the transformed INS1 832/13 beta cell line. We found that acute ablation of PERK in 832/13 beta cells mimics all of the defects seen in the beta cells of Perk-deficient mice and detailed temporal studies suggest that defects in the function of the endoplasmic reticulum may give rise to the defects in beta cell developmental and proliferation.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Ablation of PERK in INS1 832/13 beta cells results in reduced insulin gene expression, insulin content, and insulin secretion
###end title 11
###begin p 12
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 231 239 231 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 263 272 263 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 517 525 517 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 559 566 556 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ </italic>
###xml 639 647 636 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 814 816 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 977 979 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1042 1051 1039 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insulin-1</italic>
###xml 1053 1062 1050 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insulin-2</italic>
###xml 1064 1068 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA</italic>
###xml 1074 1080 1071 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut2 </italic>
###xml 1180 1185 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdx-1</italic>
###xml 1187 1193 1184 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD</italic>
###xml 1199 1203 1196 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gck </italic>
###xml 1230 1232 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1260 1270 1257 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin-1 </italic>
###xml 1274 1284 1271 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin-2 </italic>
###xml 1438 1443 1435 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 1511 1519 1508 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 1525 1526 1522 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
###xml 517 524 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1519 1523 <span type="species:ncbi:10090">mice</span>
To investigate the acute effects of ablating PERK expression, the transformed rat INS 832/13 insulin-secreting beta cells [12] were transduced with a dominant negative mutant of Perk using the adenoviral vector (AdDNPerk) yielding AdDNPerk-832/13 beta cells. The AdDNPerk transgene contains a C-terminal truncation of the kinase domain of mouse Perk [13] tagged with c-myc which was inserted into an adenoviral vector that contains a GFP marker to monitor transduction efficiency. An adenoviral vector expressing the E. coli lacZ (beta-galactosidase) denoted AdLacZ was used throughout as a control. After 24-48 hours post-transduction of AdDNPerk, greater than 90% of the 832/13 beta cells were successfully transduced as shown by expression of the GFP marker (not shown). The DNPERK protein was detected (Figure 1A) in transduced 832/13 beta cells, and significantly ablated the activity of the endogenous PERK as shown by reduced levels of phosphorylated eIF2 alpha (Figure 1A). Ablation of PERK resulted in a significant reduction of the insulin-1, insulin-2, MafA, and Glut2 mRNAs while the expression of other important genes in beta cell development and function including Pdx-1, NeuroD, and Gck were nearly normal (Figure 1B). In parallel to decreased Insulin-1 and Insulin-2 mRNA expression, insulin content per beta cell was significantly reduced as a function of the dose of DN-PERK transduced in the 832/13 beta cells (Figure 2A, B) mirroring the reduced insulin content of the pancreatic islets of Perk KO mice [6].
###end p 12
###begin p 13
###xml 14 23 14 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of <italic>AdDNPerk </italic>in 832/13 cells down-regulates insulin mRNA levels</bold>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 247 272 239 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">of AdLacZ1 and AdDNPerk1 </italic>
###xml 282 307 274 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">of AdLacZ2 and AdDNPerk2 </italic>
###xml 314 315 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 377 381 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA</italic>
###xml 383 389 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NeuroD</italic>
###xml 395 400 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glu2 </italic>
###xml 429 445 421 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk-832/13 </italic>
###xml 491 497 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
Expression of AdDNPerk in 832/13 cells down-regulates insulin mRNA levels. A. Expression of DNPERK was detected by tag c-myc antibody and the eIF2alpha [P]/total eIF2alpha was reduced when two different multiplicities of infection were used. (MOI of AdLacZ1 and AdDNPerk1 = 10; MOI of AdLacZ2 and AdDNPerk2 = 20). B. At 48 hr post-transduction, the expression of insulin gene, MafA, NeuroD, and Glu2 was significantly reduced in AdDNPerk-832/13 cells. The data are expressed relative to the AdLacZ-832/13 (= 100%) +/- SE, n = 4. *P < 0.05, **P < 0.01, ***P < 0.001.
###end p 13
###begin p 14
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 0 125 0 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ablation of PERK by <italic>AdDNPerk </italic>in 832/13 cells results in reduced insulin and proinsulin content and impaired insulin secretion</bold>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></bold>
###xml 218 227 218 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 307 308 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 381 382 381 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C</italic></bold>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 516 517 516 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic></bold>
###xml 825 839 823 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ-832/13 </italic>
Ablation of PERK by AdDNPerk in 832/13 cells results in reduced insulin and proinsulin content and impaired insulin secretion. A. At 48 hr post-transduction, insulin content was assayed by ELISA in cells infected with AdDNPerk and control virus at 5, 10 and 20 MOI. The data were normalized to DNA content. B. Proinsulin content was assayed by ELISA and normalized to DNA content. C. Insulin secretion in response to 3 and 15 mmol/l glucose was measured in cells infected with recombinant virus at 5, 10 and 20 MOI. D. Insulin secretion in response to 3 and 15 mmol/l glucose with or without 200 mumol/l tolbutamide or 250 mumol/l diaxoxide. Insulin secretion in response to 15 mM glucose in C and D was normalized to total insulin content, and was expressed as a fold increases relative to insulin secreted from the control AdLacZ-832/13 cultured in 3 m mol/l glucose. Values are means and error bars are +/- SE, n = 3, *p < 0.05.
###end p 14
###begin p 15
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 441 448 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ </italic>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 482 490 482 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Islets isolated from neonatal Perk KO mice exhibited an almost complete ablation of glucose-stimulated insulin secretion (GSIS) [6]. To determine if an acute deficiency of PERK impacts insulin secretion, 832/13 beta cells were transduced with AdDNPerk. Forty-eight hours post-transduction of AdDNPerk-832/13 cells showed a 3-fold reduction in insulin secretion in response to 15 mM glucose stimulation compared to 832/13 transduced with the AdLacZ control (Figure 2C). Treatment of AdDNPerk-832/13 cells with tolbutamide, a KATP channel blocker, also showed reduced enhancement of glucose stimulated insulin secretion compared to the control cells. Treatment with diazoxide, a KATP channel opener, blocked glucose-stimulated insulin secretion (Figure 2D) in both genotypes as expected. We conclude that the reduced GSIS is due to a combination of decreased insulin content as well from a partial reduction in KATP-dependent insulin secretion.
###end p 15
###begin title 16
###xml 17 26 17 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
Proliferation of AdDNPerk 832/13 beta cells is reduced
###end title 16
###begin p 17
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
The cell proliferation rate of AdDNPerk-832/13 and LacZ-832/13 beta cells was estimated by BrdU incorporation. AdDNPerk-832/13 exhibited a 25% reduction in proliferation compared to AdLacZ-832/13, consistent with a general observation of the relative growth rates of these cells across several independent experiments (Figure 3A). Cell death, estimated as TUNEL positive cells, was low in both genotypes and not significantly different from each other (Figure 3B).
###end p 17
###begin p 18
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ablation of PERK in 832/13 cells impairs beta cell proliferation but does not increase cell death</bold>
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. BrdU </italic>
###xml 169 178 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ </italic>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 423 432 423 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 509 516 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ </italic>
Ablation of PERK in 832/13 cells impairs beta cell proliferation but does not increase cell death. A. BrdU incorporation is significantly reduced in cells infected with AdDNPerk at 24 hr post-transduction cells compared to AdLacZ infected cells. The data represent two thousand cells for each treatment in two independent experiments (*p < 0.05). B. Cell Death. The percentage TUNEL-positive 832/13 cells infected with the AdDNPerk was low and was not significantly different than the cells infected with the AdLacZ control. A MOI of 20 was used for these experiments.
###end p 18
###begin title 19
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
Accumulation of proinsulin in the ER occurs in the absence of increased protein synthesis in Perk deficient beta cells
###end title 19
###begin p 20
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 229 237 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 743 749 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
Proinsulin is co-translationally imported into the endoplasmic reticulum and rapidly enters the Golgi complex [14,15] where it accumulates in beta cells prior to its maturation and formation of insulin secretory granules [6]. In Perk KO mice, however, a large fraction (ca. 20-40%) of the beta cells exhibited grossly distended endoplasmic reticulum with a very high accumulation of proinsulin [6]; these abnormal cells are denoted herein as Impacted-ER beta cells. Acute ablation of PERK in 832/13 cells also resulted in appearance of Impacted-ER cells as characterized by a shift of the majority of proinsulin from the Golgi complex to the endoplasmic reticulum (Figure 4A). In contrast we have not observed Impacted-ER cells in the control AdLacZ-832/13 cells (Figure 4A) or in the pancreatic islets of wild-type mice (Figure 4B).
###end p 20
###begin p 21
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ablation of PERK resulted in abnormal accumulation of proinsulin and ERp72 in beta cells</bold>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 281 290 281 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
###xml 567 575 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
Ablation of PERK resulted in abnormal accumulation of proinsulin and ERp72 in beta cells. A. At 48 hr post-transduction, some of AdDNPerk-infected 832/13 cells had abnormal accumulation of proinsulin in the ER (upper panel, left arrow). ERp72 is upregulated in cells infected with AdDNPerk and the increase in ERp72 staining appeared earlier than the Impacted-ER phenotype (upper panel, right arrow). In contrast, cells infected with the AdLacZ-832/13 control exhibited normal Golgi localization of proinsulin (lower panel, arrow). B. ERp72 is abnormally retained in Perk KO beta cells in neonatal P1 mice. Double staining for both proinsulin and ERp72 demonstrates higher expression of ERp72 in beta cells than in exocrine cells and other endocrine cells in both WT and KO. In KO cells the ERp72 antibody stains balloon-like structures (shown in the inset). The data represent three or more independent mice for each genotype.
###end p 21
###begin p 22
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
When PERK is highly activated by ER stress it represses global protein synthesis [16,17], and it has been speculated that the loss of PERK function may result in derepressed protein synthesis and over accumulation of proteins in the ER. Conversely, we found that global protein synthesis rates were not elevated in AdDNPerk-832/13 cells (Figure 5A) and proinsulin content was reduced, not increased (Figure 2B). Thus the over accumulation of proinsulin in the ER is not due to over synthesis of proinsulin.
###end p 22
###begin p 23
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Global protein synthesis is normal following acute ablation of PERK</bold>
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
###xml 397 405 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
Global protein synthesis is normal following acute ablation of PERK. A. Incorporation of 35S translabel into total TCA-precipitable protein did not differ between AdDNPerk-infected and AdLacZ-infected cells at 24 hr (A) or 16 hr post-transduction (data not shown). Values are means +/- SE from three replicate samples. B. Cyclohexamide (CHX) did not inhibit the induction of ERp72 and BiP mRNA in AdDNPerk-infected 832/13 cells. At 12 hr post-transduction, cells were treated with 5 mg/ml CHX for 4 hours before RNA was extracted for Real-time quantitative RT-PCR. Values are means +/- SE, from three replicate samples.
###end p 23
###begin title 24
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
ERp72 and GRP78/BiP expression are induced first after initiating acute ablation of Perk followed by other changes in gene expression
###end title 24
###begin p 25
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 271 280 271 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 333 341 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1</italic>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins2</italic>
###xml 396 402 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut2 </italic>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 494 502 494 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA </italic>
###xml 623 631 623 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 643 651 643 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 682 688 682 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 692 702 692 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRP78/BiP </italic>
###xml 895 896 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 993 997 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 1112 1121 1109 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 1128 1129 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1132 1136 1129 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins1</italic>
###xml 1138 1142 1135 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins2</italic>
###xml 1148 1153 1145 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA </italic>
###xml 1227 1233 1224 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 1237 1247 1234 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRP78/BiP </italic>
###xml 1299 1307 1296 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 1447 1448 1444 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1451 1460 1448 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyclin A </italic>
###xml 1464 1473 1461 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D </italic>
###xml 1500 1508 1497 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 1567 1573 1564 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xbp-1 </italic>
###xml 1759 1764 1756 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 1782 1790 1779 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 1838 1844 1835 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xbp-1 </italic>
###xml 1857 1858 1854 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1894 1910 1891 1907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk-832/13 </italic>
###xml 2015 2017 2012 2014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 2149 2155 2146 2152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 2159 2169 2156 2166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRP78/BiP </italic>
###xml 2181 2189 2178 2186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 2314 2320 2311 2317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 2324 2334 2321 2331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRP78/BiP </italic>
###xml 2337 2345 2334 2342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 2372 2374 2369 2371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 1307 1311 <span type="species:ncbi:10090">mice</span>
###xml 1774 1778 <span type="species:ncbi:10090">mice</span>
To further explore the possible causes and consequences of proinsulin retention in ER in Perk-deficient beta cells, the expression of key ER chaperone, trafficking, ERAD genes were examined in 832/13 cells that had been transduced with a relatively low titer (10 MOI) of AdDNPerk and in pancreatic islets isolated from neonatal (P1) Perk KO mice. Using a lower titer of AdDNPerk, Ins1, Ins2, and Glut2 were expressed at normal levels (Figure 6), unlike that seen at high titers (Figure 1B) and Perk KO islets where these genes were significantly repressed compared to control. MafA mRNA was significantly repressed in both AdDNPerk-832/13 and Perk KO islets. The ER chaperone genes ERp72 and GRP78/BiP were substantially induced while most other ER chaperones (ERp58, ERp57, Ero1beta, and Ero1L) and ERAD associated (Psma5, Sec61a, Sec63, and Der1) genes were not significantly elevated (Figure 6). To determine the temporal pattern of the induction of these genes following acute ablation of Perk, the mRNA level of several genes was assessed at various time points after transduction of 832/13 beta cells with AdDNPerk (Table 1). Ins1, Ins2, and MafA were not significantly reduced until 36 hours after transduction, whereas ERp72 and GRP78/BiP were induced after only 16 hours. The beta cells of Perk KO mice showed reduced expression of several cell-cycle and proliferation genes associated with a substantial reduction in beta proliferation [6]. Cyclin A and cyclin D mRNAs were also reduced in AdDNPerk-832/13 beta cells but not until 48 hours. The splicing of Xbp-1 mRNA is a sensitive indicator of the ER stress response, and the over accumulation of proinsulin is predicted to elicit and an ER stress response, but surprisingly neither beta cells in Perk deficient mice or AdDNPerk-832/13 beta cells showed increased splicing of Xbp-1 mRNA (Figure 6). Increased expression of ERp72 in AdDNPerk-832/13 cells was also seen by immunohistochemistry earlier than the appearance of the Impacted-ER cells (Figure 4A). We further tested the hypothesis that unrepressed global protein synthesis is responsible for the induction of the ER chaperones ERp72 and GRP78/BiP by treating AdDNPerk-832/13 beta cells with cyclohexamide, a potent inhibitor of protein synthesis. Cyclohexamide did not block the induction of ERp72 and GRP78/BiP in AdDNPerk-832/13 beta cells (Figure 5B) and did not reduce or delay the appearance of Impacted-ER beta cells (data not shown) thus arguing against this hypothesis.
###end p 25
###begin p 26
Temporal Changes in gene expression following Perk ablation in 832/13 cells
###end p 26
###begin p 27
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
The values represent the levels of specific mRNAs in AdDNPerk-transduced cells normalized to AdLacZ-transduced controls as determined by real-time quantitative RT-PCR. Time points (hr) indicate hours after transduction. The data are the average of two to five independent experiments. * P < 0.05
###end p 27
###begin p 28
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of gene expression in Perk deficient islets and 832/13 transformed beta cells</bold>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 136 152 136 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk 832/13 </italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 186 190 186 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 201 215 201 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ 832/13 </italic>
###xml 439 447 439 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xbp-1 </italic>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xpb-1 </italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xbp-1 </italic>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
Comparison of gene expression in Perk deficient islets and 832/13 transformed beta cells. The expression of mRNAs in Perk-/- islets and AdDNPerk 832/13 beta cells were normalized to Perk+/+ islets and AdLacZ 832/13 beta cells, respectively. For the 832/13 cells a low dose of adenovirus (MOI = 5) was used, and the data from 2 to 5 independent experiments were analyzed. For islets, mRNA expression was also quantified from 5-9 WT and 4-9 Perk KO mice. For Xbp-1 the spliced Xpb-1 mRNA form was normalized to total Xbp-1 mRNA. Not assayed for specific mRNAs denoted as n.a.
###end p 28
###begin p 29
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATF6 </italic>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNPerk </italic>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 488 494 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNPerk</italic>
###xml 682 688 682 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 692 696 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BiP </italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 216 221 <span type="species:ncbi:9606">human</span>
ERp72 and GRP78/BiP are induced by the transcription factor ATF6 [18]. Although we could not readily detect the active nuclear form of ATF6 in 832/13 beta cells (not shown), we examined the processing of ATF6 in the human embryonic kidney AD293 cell line co-transfected with plasmids bearing ATF6 and DNPerk or vector control and treated with DTT, an ER stress inducer. As expected, ATF6 processing was induced by DTT in control cells (Figure 7). However, in AD293 cells transfected with DNPerk, the processed nuclear form of ATF6 was present at relatively high levels in untreated cells and not further induced by DTT. As new protein synthesis is not required for the induction of ERp72 and BiP mRNA expression following acute ablation of Perk, post-translational processing of ATF6 to its active nuclear form is consistent with the hypothesis that ATF6 is responsible for their induction.
###end p 29
###begin p 30
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells</italic>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Basal levels of processed ATF6 are elevated in PERK-ablated <italic>cells</italic></bold>
###xml 67 79 67 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AD293 cells </italic>
###xml 104 115 104 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EYFP-ATF6a </italic>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNPerk</italic>
Basal levels of processed ATF6 are elevated in PERK-ablated cells. AD293 cells were co-transfected with EYFP-ATF6a and either empty vector or DNPerk. Each type of co-transfection was treated with and without 5 mM DTT for 1 hr. Immunoblotting with an antibody that recognizes tagged ATF6 shows both the ER-resident uncleaved and cleaved nuclear forms. Quantification of the nuclear ATF6 expressed as a percentage of the full-length form is shown below the tubulin panel.
###end p 30
###begin title 31
ERp72 protein expression and oxidized state is increased in PERK-ablated 832/13 cells
###end title 31
###begin p 32
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 429 435 429 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 478 486 478 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 567 575 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1016 1024 1016 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
ERp72, a family member of the protein disulfide isomerases (PDI), is localized in the ER and plays a major role in quality control and folding [19-22]. These PDI enzymes are particularly important for ER client proteins such as proinsulin that depend upon cysteine disulfide bonds for their folded structure. Indeed we have found that ERp72 was physically associated with proinsulin in 832/13 cells (data not shown). As seen for ERp72 mRNA levels, ERp72 protein was elevated in AdDNPerk-832/13 beta cells and similar increases were seen for GRP78/BiP (Figure 8A). In Perk KO mice we found that the amount of ERp72 was elevated (Figure 8B) and became localized to large balloon-like structures in Impacted-ER cells (Figure 4B). Comparison of the ERp72 localization seen in IHC images (Figure 4B) to TEM images of Impacted-ER beta cells [6] suggest that these structures correspond to one of two types of distended ER most similar to Russell bodies [23,24]. These ERp72 enriched structures were rarely observed in the AdDNPerk-832/13 cells.
###end p 32
###begin p 33
###xml 82 98 82 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk 832/13 </italic>
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 and GRP78/BiP protein are elevated and ERp72 oxidized state is increased in <italic>AdDNPerk 832/13 </italic>beta cells</bold>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 621 630 621 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk </italic>
###xml 662 668 662 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
ERp72 and GRP78/BiP protein are elevated and ERp72 oxidized state is increased in AdDNPerk 832/13 beta cells. A. Triplicate samples were probed with antibodies to ERp72, ERp57, BiP and actin, which served as the loading control. B. ERp72 expression was increased in islets from P2 Perk KO mice. Samples are from duplicate mice for each genotype. C. At 24 hr or 36 hr post-transduction, protein samples were isolated and treated with AMS to differentiate the reduced and oxidized forms of ERp72 and ERp57 on PAGE gels. Western blots showed increased oxidized isoforms of both ERp72 and ERp57 in 832/13 cells infected with AdDNPerk compared to cells infected with AdLacZ.
###end p 33
###begin p 34
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
The redox state of the PDI family of ER folding enzymes including ERp72 and ERp57 is known to vary according to changes in the oxidative and functional states of the ER. In addition to increased levels of ERp72 protein, AdDNPerk-832/13 beta cells exhibited an increase in the oxidized isoforms of ERp72 and ERp57 (Figure 8C) that were first seen at 24 hours post transduction and increased significantly by 36 hours.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 189 197 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 643 651 643 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 762 770 762 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 919 927 919 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 967 975 967 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 282 285 <span type="species:ncbi:10116">rat</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 677 683 <span type="species:ncbi:9606">humans</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
Despite the vast differences between the milieu and ontogeny of cultured beta cells and native beta cells in the endocrine pancreas, we found that the array of defects in the beta cells of Perk KO mice [6] were remarkably present following acute ablation of Perk in the transformed rat INS1 832/13 beta cells. These defects include reduced cell proliferation (without changes in cell death), reduced expression of proinsulin and insulin, reduced glucose-stimulated insulin-secretion, and abnormal retention of proinsulin in the ER leading some cells to have a highly distended ER. That these defects underlie the cause of neonatal diabetes in Perk KO mice, and by inference in humans with the Wolcott Rallison syndrome, was shown by the study of tissue-specific Perk KO mice and the ability of a beta cell specific-Perk transgene to rescue diabetes [6,7,25]. Given the close correspondence of cellular pathology of the AdDNPerk-832/13 beta cells to the beta cells of Perk KO mice, we were encouraged to take advantage of cultured beta cells to elucidate the molecular function of PERK in regulating beta cell development and physiology.
###end p 36
###begin p 37
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 189 197 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins-1</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins-2</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MafA</italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 404 414 404 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRP78/BiP </italic>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 855 856 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 865 873 865 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 1194 1195 1194 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1217 1221 1217 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 1508 1514 1508 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ERp72 </italic>
###xml 1518 1528 1518 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRP78/BiP </italic>
###xml 1549 1557 1549 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 628 634 <span type="species:ncbi:9606">humans</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
Acute ablation of Perk, afforded by transduction of the dominant negative Perk transgene, allowed us to determine the progress and order of the ensuing defects over time. As we had seen in Perk KO mice, the expression of insulin synthesis genes Ins-1, Ins-2, and MafA) and cell cycle genes was reduced but the reduction in their expression lagged behind the induction of the ER chaperone genes ERp72 and GRP78/BiP thus suggesting that a perturbation in the ER may result in repression of genes involved in beta cell function and proliferation. Initial reports showing that loss of PERK function resulted in neonatal diabetes in humans and mice [2,4,5] suggested that the molecular defect was related to the function of PERK in the regulation of the ER stress - Unfolded Protein Response (UPR). Our extensive analyses of Perk-deficient beta cells in mice [6] and in AdDNPerk-832/13 beta cells in culture have not supported this hypothesis. The original hypothesis assumed that global protein synthesis would be derepressed as a direct consequence of the absence of PERK, and that this would result in uncontrolled protein synthesis and overloading of the ER culminating in apoptotic cell death [4]. Although the ER in Perk-deficient beta cells show marked accumulation of proinsulin, we found that global protein synthesis was not elevated nor was there an elevation in the proinsulin content in beta cells. Cell death did not increase, but instead cell proliferation was ablated. Moreover, the expression of ERp72 and GRP78/BiP was still induced in AdDNPerk-832/13 beta cells after blocking protein synthesis with cyclohexamide suggesting that their induction was not due to protein overload.
###end p 37
###begin p 38
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
ERp72 and GRP78/BiP are positively regulated and insulin gene expression is negatively regulated by ATF6 [18,26], and we found that the processed nuclear form of ATF6 was substantially increased in PERK-ablated AD293 cells. Treatment of cells with Brefeldin-A also induces the processing of the ATF6 [27], which is caused by relocalization of the S2P protease from the Golgi to the ER. We found that the S2P protease is indeed mislocalized in PERK-ablated AD293 cells and is associated with ER markers (Gupta, et al. unpublished data), which suggests that the increased basal level of the nuclear form of ATF6 is due to mislocalization of the proteases that cleave precursor ATF6 rather than by ER stress. Further studies are required to confirm the importance of these findings in insulin-secreting beta cells.
###end p 38
###begin p 39
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
In addition to its role in repressing global protein synthesis during ER stress, PERK positively regulates the translation of ATF4, which in turn upregulates GADD153/CHOP [8,28,29]. Mutations in these downstream genes, however, do not lead to diabetes in mice, [6,7] thus arguing against the hypothesis that diabetes associated with Perk deficiency is related to the role of PERK in regulating the unfolded protein response. Considerable evidence suggests that PERK is important for mediating the ER stress response in adult beta cells [11,30-32], but we argue that the primary function of PERK in beta cells is to regulate beta cell development and function during the fetal-neonatal period. Interestingly IRE1, another mediator of the ER stress response, has also been shown to have an important beta cell function by positively regulating insulin biosynthesis [33].
###end p 39
###begin p 40
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1283 1285 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1890 1892 1890 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1893 1895 1893 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1958 1960 1958 1960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 2119 2121 2119 2121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
We speculate that the Impacted-ER phenotype, characterized by gross distension of the endoplasmic reticulum and abnormal retention of proinsulin observed in Perk-deficient beta cells, represents the extreme manifestation of ER dysfunction. The induction of ERp72 and GRP/78 mRNA expression is the first hint of ER dysfunction, and is followed by increased levels of these proteins and the oxidized isoform of ERp72 and ERp57. The increased oxidized isoforms of ERp72 and ERp57 suggests that redox state of the ER is abnormal or that the oxidation and reduction of protein disulfides is imbalanced. The formation of disulfide bonds is essential for the proper folding proinsulin and subsequent maturation of insulin [14]. The protein disulfide isomerase family including ERp72, PDI, and ERp57, mediate their oxidative protein folding functions by forming transient mixed disulfides with ER client proteins [34,35] such as proinsulin. In addition to catalyzing the proper folding of proteins in preparation for transport from the ER to the Golgi, the PDI enzymes participate in ER associated protein degradation (ERAD) by reducing thiols of misfolded proteins in preparation for retrotranslocation to the cytoplasm for proteosomal degradation [20,34]. Recently Forster and colleagues [19] have shown that ERp72 and PDI have opposing functions in the ER. ERp72 assists proper protein folding whereas PDI facilitates unfolding of misfolded proteins in preparation for proteosomal degradation. We propose that PERK regulates the expression of key genes that encode ER redox and protein folding functions in the insulin-secreting beta cells during the dynamic metabolic changes that occur during the developmental transitions through embryonic, fetal, neonatal, and juvenile stages. PERK enzyme activity is regulated through its ER luminal domain via binding of GRP78/BiP complexed with calcium [36,37]. Physiological changes in ER calcium modulate PERK activity [10] as well as insulin secretion. The regulation of ER calcium is coupled to the redox state of specific ER proteins including SERCA, the major ER calcium pump [38]. We speculate that PERK acts as an ER calcium sensor that couples ER functions of folding, quality control, and protein trafficking that are intimately tied to the redox state of the ER as a function of the dynamic changes in the physiological environment of the beta cell during the early developmental transitions.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 291 299 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk KO </italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk</italic>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
We found that acute ablation of PERK in the transformed 832/13 beta cell line leads to reduced proliferation and reduced insulin gene expression, insulin content, and insulin secretion, demonstrating that acute ablation of PERK recapitulates the major cellular and molecular defects seen in Perk KO mice. In addition proinsulin accumulates abnormally in the ER, which occurs after the elevation of two key chaperone proteins GRP78/BiP and ERp72. ERp72 accumulates in a sub compartment of the ER and its oxidized isoform is substantially increased. Because the changes in the expression of GRP78/BiP and ERp72 are the earliest changes observed after ablation of Perk, we suggest that ER dysfunctions give rise to defects in proinsulin trafficking, insulin secretion, and cell proliferation.
###end p 42
###begin title 43
Methods
###end title 43
###begin title 44
Cell culture
###end title 44
###begin p 45
###xml 354 355 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 211 217 <span type="species:ncbi:9913">bovine</span>
INS-1 832/13 insulin-secreting beta cells were obtained from Dr. Christopher Newgard (Duke University). The 832/13 cells were cultured in RPMI-1640 (Mediatech Cellgro) supplemented with 11 mM glucose, 10% fetal bovine serum, 10 mM HEPES, 1 mM sodium pyruvate, 50 muM beta-mercaptoethanol and Antibiotic Antimycotic Solution (Sigma) at 37degreesC in 5% CO2, 95% air. The cells were sub-cultured twice weekly. For determining relative proliferation, BrdU (1 mM) was added to the cell for 1 hr followed by permeabilization and fixation for 10 minutes with 4% formaldehyde, 0.1% Triton x-100 in PBS. The cells were then denatured with 1N HCL for 30 mins, and anti-BrdU (1:50, DAKO) applied for 1 hour. For estimating cell death the DeadEndTM Fluorometric TUNEL System (Promega, Inc.) was used. Cells were fixed in 4% methanol-free formaldehyde solution for 10 min, permeabilized with 0.2% Triton X-100 solution for 5 minutes, and labeled according to instructions of the kit.
###end p 45
###begin title 46
Proinsulin content, insulin content and insulin secretion
###end title 46
###begin p 47
###xml 105 111 <span type="species:ncbi:9913">bovine</span>
###xml 234 239 <span type="species:ncbi:10090">Mouse</span>
After 48 hr post-transduction, 832/13 cell pellets were sonicated in 1 mol/l acetic acid containing 0.1% bovine serum albumin. Aliquots of cell extracts were assayed for proinsulin and insulin content using proinsulin EIA (ALPCO) and Mouse Insulin Ultrasensitive EIA (ALPCO), respectively. The data were normalized to DNA content. Insulin secretion was assayed at 3 mmol and 15 mmol/l glucose. For KATP channel dependent secretion assay, 200 mumol/l tolbutamide or 250 mumol/l diazoxide were added.
###end p 47
###begin title 48
Plasmids and adenovirus production
###end title 48
###begin p 49
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 57 67 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PERK&#916;C</italic>
###xml 129 140 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PERK&#916;C </italic>
###xml 310 321 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PERK&#916;C </italic>
###xml 390 393 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 399 402 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 527 535 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdDNPerk</italic>
###xml 896 902 866 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AdLacZ</italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 858 861 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The c-myc tagged dominant-negative mouse Perk transgene (PERKDeltaC) was kindly provided by Dr. David Ron (New York University). PERKDeltaC was generated by deleting the kinase domain of Perk residing in the carboxy terminal coding sequence, retaining the amino terminal ER luminal domain (Harding, 1999). The PERKDeltaC transgene was excised by us from the parent vector by digestion with Spe1 and Xho1 and then inserted to the Adenovirus vector pShuttle-IERS-hrGFP-1 (Stratagene). The resulting construct, which we denote as AdDNPerk, was transfected into AD-293 cells using the MBS Mammalian Transfection kit (Stratagene) for amplification. The adenovirus was then purified by Adeno-Xtrade mark Virus Purification kit (Clontech) and the titer was determined by the QuickTitertrade mark Adenovirus Titer Immunoasssay Kit (Cell Biolabs, Inc.). The pShuttle-CMV-lacZ transgene, denoted herein as AdLacZ, served as a control. Transduction of 832/13 cells was carried out at a cell confluency of about 70%, at different multiplicities of infection (MOI) from 5 to 20. A MOI of 20 was used in most experiments unless otherwise stated. After 2 hours of incubation with the virus at 37degreesC, 5% CO2, cells were washed once in RPMI and cultured for an additional 6-48 h before assay.
###end p 49
###begin p 50
To assess ATF6 processing the expression plasmid pCMVshort-EYFP-ATF6-alpha, provided by Kazutoshi Mori, was transfected into AD293 cells.
###end p 50
###begin title 51
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strains
###end title 51
###begin p 52
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Perk </italic>
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
The Perk knockout strain was previously generated by us [5] and are congenic for C57BL/6J or 129SvEvTac. Both congenic strains exhibited all of the beta cell defects previously described [5].
###end p 52
###begin title 53
Islet isolation
###end title 53
###begin p 54
###xml 31 35 <span type="species:ncbi:10090">mice</span>
The pancreata from E18.5 to p2 mice were inflated in situ by injecting 3 mg/ml Collagenase P (Invitrogen) in HBSS (Sigma) and digestion was carried out at 37degreesC for about 12 mins at which time 1 ml of ice-cold HBSS was added to stop the enzyme reactions. The dispersed pancreatic tissue was pelleted and washed once with HBSS. The pellets were then suspended in 1 ml Histopaque-1077, overlaid with 0.2 ml RPMI 1640 medium and centrifuged at 890 g for 12 min to separate the islet from the other cell types and residual debris. Islets were manually picked under a dissection microscope and washed once with ice-cold HBSS.
###end p 54
###begin title 55
Gene expression levels
###end title 55
###begin p 56
###xml 357 364 333 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xbp1-s </italic>
###xml 398 405 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xbp1-t </italic>
###xml 534 1743 510 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actin 5'-GCCCTGAGGCTCTTTTCC-3', 5'-TGCCACAGGATTCCATACCC-3'; GAPDH 5'-GGAGCGAGACCCCACTAACA-3', 5'-ACATACTCAGCACCGGCCTC-3'; Insulin I 5'-AGCATCTTTGTGGTCCCCAC-3', 5'-CCCCACACACCAGGTAA-3'; Insulin II 5'-CAGAAGCGTGGCATTGTAGA-3', 5'-TTGCAGTAGTTCTCCAGCTGG-3'; MafA, 5'-GCTGGTATCCATGTCCGTGC-3', 5'-GTCGGATGACCTCCTCCTTG-3'; Pdx-1, 5'-GAGCGTTCCAATACGGACCA-3',5'-TCAGCCGTTCTGTTTCTGGG-3'; ERP72, 5'-TTCCACGTGATGGATGTTCAG-3', 5'-AGTCTTACGATGGCCCACCA-3'; ERP57, 5'-GGCGGATGCAACATATCACC-3', 5'-TGTGGTTCGTACTGTCCCCC-3'; ERP58, 5'-CAAGAGGCTTGCCCCTGAG-3', 5'-GGTGTTTGTGTTGGCAGTGC-3'; Hrd1, 5'-TGGCTTTGAGTACGCCATTCT-3', 5'-CCACGGAGTGCAGCACATAC-3'; Ero1 L, 5'-AAACCCTGCCATTCTGATGAA-3', 5'-ACTCATCCACGGCTCCAA GT-3'; Ero1 beta, 5'-TGATTCGCAGGACCACTTTTG-3', 5'-TAGCCAGTGTACCGTTCCGG-3'; Herpud1, 5'-CCCACCTGAGCCGAGTCTAC-3', 5'-CTTGGAGACACTGGTGATCCAA-3'; ATF3, 5'-CCT ATGCAAAGCAGGATCCC-3', 5'-GCGTTGTCAGCCACAGTGG-3'; GRP94, 5'-CTGGGTCAAGCAGAAAGGAG-3' 5'-TCTCTGTTGCTTCCCGACTT-3'; BiP, 5'-GCTTCGTGTCTCCTCCTGAC-3', 5'-TAGGAGTCCAGCAACAGGCT-3'; Chop, 5'-CCAACAGAGGTCACACGCAC-3', 5'-TGACTGGAATCTGGAGAGCGA-3'; Xbp1-spliced, 5'-GAGTCCGCAGCAGGTG-3', 5'-GTGTCAGAGTCCATGGGA-3'; Xbp1-total, 5'-CACCTTCTTGCCTGCTGGAC-3', 5'-GGGAGCCCTCATATCCACAGT-3'</italic>
###xml 1787 1796 1763 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actin, 5'</italic>
###xml 1824 1830 1800 1806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3', 5'</italic>
###xml 1862 1871 1838 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH, 5'</italic>
###xml 1893 1899 1869 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3', 5'</italic>
###xml 1923 3441 1899 3417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">; Insulin I, 5'-CAGCACCTTTGTGGTCCTCA-3', 5'-CCCACACACCAGGTACAGAGC-3'; Insulin II, 5'-CTGCCCAGGCTTTTGTCAAA-3', 5'-CTTCCACCAAGTGAGAACCACA-3'; MafA, 5'-GGCACATTCTGGAGAGCGA-3', 5'-CCCGCCAACTTCTCGTATTTC-3'; Pdx-1, 5'-CCACCAAAGCTCACGCGT-3', 5'-CTGCGTATGCACCTCCTGC-3'; NeuroD, 5'-GCTTGAAGCCATGAATGCAG-3', 5'-TCCTCTCCCCCATTTCTCAGA-3'; ERp72, 5'-TCTAACCAATCACCGGGCTG-3',5'-TCATGGTAAGGTGCCGAGG-3'; BiP, 5'-ACCCTTACTCGGGCCAAATT-3', 5'-AGAGCGGAACAGGTCCATGT-3'; ERp58, 5'-CGAAAACTTCGAGAGTCGCG-3', 5'-GCAAGCCTCTTGCAATGTCC-3'; ERp57,, 5'-GGACTCAAG CGAAGTGACGG-3'; 5'-TCTGCTGCCAGCAAGAACTG-3'; Ero1 L, 5'-TTCACTGAGGAGGGCGGTT-3', 5'-CAGGACGGTCACTGCAATCA-3'; Ero1 beta, 5'-GTGCTTTGTCAAAGGTGG CC3'; 5'-GCAGAAGGGTCTTGGTGTCAG-3'; Crebpp1, 5'-ACGCCGGAGTCAATTCCTATC-3', 5'-GAGCTGATGTTGCGG GAAGA-3'; Psma5, 5'-TCACACCCCTGTCGTACTCG-3', 5'-TTTCAGTCGTGTGGCCTTTG-3'; Sec61a, 5'-GCTTCTGAATTT CCGGCAAG-3', 5'-AGGCAGGGAGTGTAGTCGGAC-3'; Sec63, 5'-TGGGTGAGTGAGACCTTCCC-3', 5'-AACCCCGGATCTTCCCAGTA-3'; Der1, 5'-CACCAGCCATGCTAAGCAGA-3', 5'-TCAGTGTGGGTCAGGTCCAAG-3'; Herpud1, 5'-GTGCTCTGTTGCTGGAGGCT-3', 5'-AGCACATCGTCATCCTGTGG-3'; Xbp-1 spliced, 5'-CTGAGTCCGAATCAGGTGCAG-3', 5'-ATCCATGGGAAGATGTTCTGG-3'; Xbp-1 total, 5'-CCCTTCTCCCTTCAGCGAC-3', 5'-CGTTGGCAAAAGTGTCCTCC-3'; Rat cyclin D2, 5'-TGCTGACCAAGATCACCCAC-3', 5'-CCTGGCAGGCTTTGAGACAA-3'; Rat cyclin B2, 5'-GCCCCTGAGGATGTCTCCAT-3', 5'-AGAGAAAGCTTGGCAGAGGCT-3'; Rat cyclin A2, 5'-AGTGTGAAGATGCCCTGGCT-3', 5'-TGGCTCCGGGTAAAGAGACA-3'; Rat cyclin E, 5'-GTCGCAGGGTTGCTGTTGAT-3', 5'-CATGCTTGCTCACGACCACT-3'</italic>
###xml 494 499 <span type="species:ncbi:10090">mouse</span>
###xml 1749 1752 <span type="species:ncbi:10116">rat</span>
###xml 3159 3162 <span type="species:ncbi:10116">Rat</span>
###xml 3230 3233 <span type="species:ncbi:10116">Rat</span>
###xml 3302 3305 <span type="species:ncbi:10116">Rat</span>
###xml 3373 3376 <span type="species:ncbi:10116">Rat</span>
Quantification of gene expression was carried out by using qPCR Core Kit for SYBR Green I (Eurogentec) amplifying cDNA with the ABI Prism 7000 Sequence Detection System. The following cycling conditions were used for all primer pairs: 50degreesC (2 minutes), 95degreesC (10 minutes), 40 cycles of (95degreesC [15 seconds], 60degreesC [1 minute]). Levels of Xbp1-s (spliced form) were normalized to Xbp1-t (total) levels. All other mRNAs were normalized to the levels of actin and/or GAPDH. The mouse primer sequences were as follows: actin 5'-GCCCTGAGGCTCTTTTCC-3', 5'-TGCCACAGGATTCCATACCC-3'; GAPDH 5'-GGAGCGAGACCCCACTAACA-3', 5'-ACATACTCAGCACCGGCCTC-3'; Insulin I 5'-AGCATCTTTGTGGTCCCCAC-3', 5'-CCCCACACACCAGGTAA-3'; Insulin II 5'-CAGAAGCGTGGCATTGTAGA-3', 5'-TTGCAGTAGTTCTCCAGCTGG-3'; MafA, 5'-GCTGGTATCCATGTCCGTGC-3', 5'-GTCGGATGACCTCCTCCTTG-3'; Pdx-1, 5'-GAGCGTTCCAATACGGACCA-3',5'-TCAGCCGTTCTGTTTCTGGG-3'; ERP72, 5'-TTCCACGTGATGGATGTTCAG-3', 5'-AGTCTTACGATGGCCCACCA-3'; ERP57, 5'-GGCGGATGCAACATATCACC-3', 5'-TGTGGTTCGTACTGTCCCCC-3'; ERP58, 5'-CAAGAGGCTTGCCCCTGAG-3', 5'-GGTGTTTGTGTTGGCAGTGC-3'; Hrd1, 5'-TGGCTTTGAGTACGCCATTCT-3', 5'-CCACGGAGTGCAGCACATAC-3'; Ero1 L, 5'-AAACCCTGCCATTCTGATGAA-3', 5'-ACTCATCCACGGCTCCAA GT-3'; Ero1 beta, 5'-TGATTCGCAGGACCACTTTTG-3', 5'-TAGCCAGTGTACCGTTCCGG-3'; Herpud1, 5'-CCCACCTGAGCCGAGTCTAC-3', 5'-CTTGGAGACACTGGTGATCCAA-3'; ATF3, 5'-CCT ATGCAAAGCAGGATCCC-3', 5'-GCGTTGTCAGCCACAGTGG-3'; GRP94, 5'-CTGGGTCAAGCAGAAAGGAG-3' 5'-TCTCTGTTGCTTCCCGACTT-3'; BiP, 5'-GCTTCGTGTCTCCTCCTGAC-3', 5'-TAGGAGTCCAGCAACAGGCT-3'; Chop, 5'-CCAACAGAGGTCACACGCAC-3', 5'-TGACTGGAATCTGGAGAGCGA-3'; Xbp1-spliced, 5'-GAGTCCGCAGCAGGTG-3', 5'-GTGTCAGAGTCCATGGGA-3'; Xbp1-total, 5'-CACCTTCTTGCCTGCTGGAC-3', 5'-GGGAGCCCTCATATCCACAGT-3'. The rat primer sequences were as follows: Actin, 5'-ATC CTG GCC TCA CTG TCC AC-3', 5'-CTA GAA GCA TTT GCG GTG CA-3'; GAPDH, 5'-CACCACCAACTGCTTAGCCC-3', 5'-TGGCATGGACTGTGGTCATG-3'; Insulin I, 5'-CAGCACCTTTGTGGTCCTCA-3', 5'-CCCACACACCAGGTACAGAGC-3'; Insulin II, 5'-CTGCCCAGGCTTTTGTCAAA-3', 5'-CTTCCACCAAGTGAGAACCACA-3'; MafA, 5'-GGCACATTCTGGAGAGCGA-3', 5'-CCCGCCAACTTCTCGTATTTC-3'; Pdx-1, 5'-CCACCAAAGCTCACGCGT-3', 5'-CTGCGTATGCACCTCCTGC-3'; NeuroD, 5'-GCTTGAAGCCATGAATGCAG-3', 5'-TCCTCTCCCCCATTTCTCAGA-3'; ERp72, 5'-TCTAACCAATCACCGGGCTG-3',5'-TCATGGTAAGGTGCCGAGG-3'; BiP, 5'-ACCCTTACTCGGGCCAAATT-3', 5'-AGAGCGGAACAGGTCCATGT-3'; ERp58, 5'-CGAAAACTTCGAGAGTCGCG-3', 5'-GCAAGCCTCTTGCAATGTCC-3'; ERp57,, 5'-GGACTCAAG CGAAGTGACGG-3'; 5'-TCTGCTGCCAGCAAGAACTG-3'; Ero1 L, 5'-TTCACTGAGGAGGGCGGTT-3', 5'-CAGGACGGTCACTGCAATCA-3'; Ero1 beta, 5'-GTGCTTTGTCAAAGGTGG CC3'; 5'-GCAGAAGGGTCTTGGTGTCAG-3'; Crebpp1, 5'-ACGCCGGAGTCAATTCCTATC-3', 5'-GAGCTGATGTTGCGG GAAGA-3'; Psma5, 5'-TCACACCCCTGTCGTACTCG-3', 5'-TTTCAGTCGTGTGGCCTTTG-3'; Sec61a, 5'-GCTTCTGAATTT CCGGCAAG-3', 5'-AGGCAGGGAGTGTAGTCGGAC-3'; Sec63, 5'-TGGGTGAGTGAGACCTTCCC-3', 5'-AACCCCGGATCTTCCCAGTA-3'; Der1, 5'-CACCAGCCATGCTAAGCAGA-3', 5'-TCAGTGTGGGTCAGGTCCAAG-3'; Herpud1, 5'-GTGCTCTGTTGCTGGAGGCT-3', 5'-AGCACATCGTCATCCTGTGG-3'; Xbp-1 spliced, 5'-CTGAGTCCGAATCAGGTGCAG-3', 5'-ATCCATGGGAAGATGTTCTGG-3'; Xbp-1 total, 5'-CCCTTCTCCCTTCAGCGAC-3', 5'-CGTTGGCAAAAGTGTCCTCC-3'; Rat cyclin D2, 5'-TGCTGACCAAGATCACCCAC-3', 5'-CCTGGCAGGCTTTGAGACAA-3'; Rat cyclin B2, 5'-GCCCCTGAGGATGTCTCCAT-3', 5'-AGAGAAAGCTTGGCAGAGGCT-3'; Rat cyclin A2, 5'-AGTGTGAAGATGCCCTGGCT-3', 5'-TGGCTCCGGGTAAAGAGACA-3'; Rat cyclin E, 5'-GTCGCAGGGTTGCTGTTGAT-3', 5'-CATGCTTGCTCACGACCACT-3'
###end p 56
###begin title 57
Western blots
###end title 57
###begin p 58
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
Total 832/13 cellular protein was extracted with RIPA buffer (1% Nonidet P40, 0.5% sodium doxycholate, 0.1% SDS, 1 x PBS, pH 8.0) containing 1x protease and phosphatase inhibitor cocktails (Sigma, Inc.) Protein expression was assayed by Western blots. Primary antibodies used in the analysis were: ERp72 (1:2500, Stressgen, Inc), GRP78/BiP (1:500, Santa Cruz, Inc), ERp57 (1:300, Santa Cruz), and anti-GFP (Sigma, Inc.) to detect EFYP-ATF6. For Western blots performed on islets from single mice, 60 islets from each mouse were dissolved in 2x SDS sample buffer and then loaded onto a 4-15% gradient gel.
###end p 58
###begin title 59
Protein synthesis
###end title 59
###begin p 60
After 16 or 24 hr post-transduction, 832/13 cells were deprived of methionine and cysteine (Met/Cys) for 30 minutes at 37degreesC in Met/Cys-free DMEM, 10% dialyzed FBS. The cells were then labeled with [35S] Met/Cys (500 muCi/ml) at 37degreesC for 0, 15, 30 minutes, and the reactions were stopped by the addition of concentrated non-radioactive Met/Cys solution (0.1 M each). After two washes with PBS, the cells were lysed in RIPA buffer and then total cellular protein was precipitated with 10% trichloroacetic acid (TCA). The precipitates were washed with 20% ice-cold acetone, air-dried for 20 minutes and then dissolved in 30 mM Tris, 7 M urea, 2 M thiourea, and 4% CHAPS. The resident radioactivity was measured by scintillation counting and normalized to total protein content.
###end p 60
###begin title 61
Immunohistochemistry
###end title 61
###begin p 62
Paraffin-embedded sections or cryo-sections were subjected to immunohistochemistry using the following primary antibodies: ERp72 (1:1000, Stressgen), insulin (1:500, Linco Research); proinsulin (1:1000, Ole D. Madsen, Beta Cell Biology Consortium); GRP78/BiP (1:500, Santa Cruz). Appropriate secondary antibodies conjugated with Alexa Fluor350, 488 or 555 dye (Molecular Probes) were used to visualize the labeled cells. Fluorescence images were captured and analyzed with a Nikon Eclipse E1000 and Image-Pro Plus (Phase 3 Imaging Systems, GE Healthcare, Inc.).
###end p 62
###begin title 63
Determination of the oxidative state of ERp72 and ERp57
###end title 63
###begin p 64
At 24 hours post-transfection, the medium was removed, and the cells were briefly washed with ice cold PBS and lysed at 0degreesC for 5 min in 20% formic acid/2% SDS. Cell lysate proteins were precipitated with 10% TCA. Precipitates were washed twice with ice cold 70% acetone. The TCA precipitates were resuspended in 80 mM Tris-HCl pH 6.8, 2% SDS, supplemented with a cocktail of protease inhibitors with or without 10 mM 4-acetamido-4'-maleimidylstilbene-2,2'-disulfonic acid (AMS, Molecular Probes, Inc.). After incubating for 30 min at room temperature and then for 10 min at 37degreesC, samples were subjected to non-reducing SDS-PAGE followed by western blot analysis to detect ERp72 and ERp57. Non-transfected cells were treated with 10 mM DTT or 5 mM diamide for 10 min at 37degreesC as reduced and oxidized controls.
###end p 64
###begin title 65
List of Abbreviations
###end title 65
###begin p 66
(ERAD): endoplasmic reticulum associated protein degradation; (eIF2alpha): eukaryotic translation initiation factor-2 alpha.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
DF carried out the cellular and molecular biology experiments and wrote the original draft of the manuscript. JW performed the protein synthesis experiment. BM provided management of the laboratory in which all experiments were conducted and edited the manuscript. SG performed the ATF6 experiments. DC and DF designed the experiments, and DC analyzed and interpreted the data and edited the manuscript. All authors read and approved of the final manuscript.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
This study was supported by grants from the National Institutes of Health (R01-DK062049 and R01-GM056957) and the Pennsylvania Department of Health TSF (D.R.C.). We are grateful to Christopher Newgard, Kazutoshi Mori, and David Ron who provided important reagents for this study. We thank Sarah Kosak for excellent technical assistance.
###end p 70
###begin article-title 71
Neonatal diabetes mellitus
###end article-title 71
###begin article-title 72
###xml 80 88 <span type="species:ncbi:9606">patients</span>
EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome
###end article-title 72
###begin article-title 73
Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity
###end article-title 73
###begin article-title 74
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival
###end article-title 74
###begin article-title 75
The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas
###end article-title 75
###begin article-title 76
PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis
###end article-title 76
###begin article-title 77
###xml 89 93 <span type="species:ncbi:10090">mice</span>
PERK eIF2 alpha kinase is required to regulate the viability of the exocrine pancreas in mice
###end article-title 77
###begin article-title 78
Regulated translation initiation controls stress-induced gene expression in mammalian cells
###end article-title 78
###begin article-title 79
Translational control and the unfolded protein response
###end article-title 79
###begin article-title 80
PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis
###end article-title 80
###begin article-title 81
Endoplasmic reticulum stress and the development of diabetes: a review
###end article-title 81
###begin article-title 82
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion
###end article-title 82
###begin article-title 83
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
###end article-title 83
###begin article-title 84
The role of assembly in insulin's biosynthesis
###end article-title 84
###begin article-title 85
###xml 110 115 <span type="species:ncbi:9606">human</span>
Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles
###end article-title 85
###begin article-title 86
Perk is essential for translational regulation and cell survival during the unfolded protein response
###end article-title 86
###begin article-title 87
PERK is responsible for the increased phosphorylation of eIF2alpha and the severe inhibition of protein synthesis after transient global brain ischemia
###end article-title 87
###begin article-title 88
Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1
###end article-title 88
###begin article-title 89
Protein disulfide isomerase-like proteins play opposing roles during retrotranslocation
###end article-title 89
###begin article-title 90
###xml 107 110 <span type="species:ncbi:10116">rat</span>
Oxidoreductase interactions include a role for ERp72 engagement with mutant thyroglobulin from the rdw/rdw rat dwarf
###end article-title 90
###begin article-title 91
Functional characterization of 3 thioredoxin homology domains of ERp72
###end article-title 91
###begin article-title 92
Stress, protein (mis)folding, and signaling: the redox connection
###end article-title 92
###begin article-title 93
Aggresomes and Russell bodies. Symptoms of cellular indigestion?
###end article-title 93
###begin article-title 94
ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies
###end article-title 94
###begin article-title 95
PERK eIF2alpha kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth factor-I derived from the liver
###end article-title 95
###begin article-title 96
Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insulin gene expression via up-regulation of orphan nuclear receptor small heterodimer partner
###end article-title 96
###begin article-title 97
Dependence of site-2 protease cleavage of ATF6 on prior site-1 protease digestion is determined by the size of the luminal domain of ATF6
###end article-title 97
###begin article-title 98
Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells
###end article-title 98
###begin article-title 99
Coping with stress: eIF2 kinases and translational control
###end article-title 99
###begin article-title 100
PERK in the life and death of the pancreatic beta-cell
###end article-title 100
###begin article-title 101
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
###end article-title 101
###begin article-title 102
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
###end article-title 102
###begin article-title 103
Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1
###end article-title 103
###begin article-title 104
ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family
###end article-title 104
###begin article-title 105
Mixed-disulfide folding intermediates between thyroglobulin and endoplasmic reticulum resident oxidoreductases ERp57 and protein disulfide isomerase
###end article-title 105
###begin article-title 106
The ER function BiP is a master regulator of ER function
###end article-title 106
###begin article-title 107
BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+
###end article-title 107
###begin article-title 108
Ca2+-dependent redox modulation of SERCA 2b by ERp57
###end article-title 108

